Birinapant
-
Out of Cash, Malvern’s TetraLogic Looks to Asset Sale, Severance
Having nearly run out of cash, the only option TetraLogic Pharmaceuticals sees to save its work over the past few years is a proposed asset…
Pioneer Partner
Founding Partners
Advertisement
Affiliate Partners
Community Partners
